Explore this recorded session from the American Diabetes Association’s 2026 Scientific Sessions debate on whether BMI should remain central to obesity diagnosis. Hear about BMI’s strengths and limitations, the Lancet Commission’s distinction between clinical and preclinical obesity, and implications for assessment, treatment, and access to care.